|
|
Volumn 21, Issue 1, 2002, Pages 12-16
|
|
Treatment of toxoplasmosis in pregnancy: Concentrations of spiramycin and neospiramycin in maternal serum and amniotic fluid
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DRUG METABOLITE;
NEOSPIRAMYCIN;
SPIRAMYCIN;
UNCLASSIFIED DRUG;
AMNION FLUID;
ARTICLE;
CIRCADIAN RHYTHM;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG BLOOD LEVEL;
DRUG METABOLISM;
FEMALE;
FETUS DISEASE;
GROWTH INHIBITION;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
IN VITRO STUDY;
INTESTINE ABSORPTION;
MATERNAL SERUM;
PATIENT COMPLIANCE;
PLACENTAL TRANSFER;
POLYMERASE CHAIN REACTION;
PREGNANCY;
PRIORITY JOURNAL;
TISSUE DISTRIBUTION;
TOXOPLASMA GONDII;
TOXOPLASMOSIS;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
AMNIOTIC FLUID;
ANIMALS;
COHORT STUDIES;
FEMALE;
FOLLOW-UP STUDIES;
GESTATIONAL AGE;
HUMANS;
MATERNAL-FETAL EXCHANGE;
POLYMERASE CHAIN REACTION;
PREGNANCY;
PREGNANCY COMPLICATIONS, PARASITIC;
PREGNANCY OUTCOME;
PRENATAL DIAGNOSIS;
SAMPLING STUDIES;
SPIRAMYCIN;
TOXOPLASMA;
TOXOPLASMOSIS;
TOXOPLASMOSIS, CONGENITAL;
TREATMENT OUTCOME;
|
|
EID: 0036175080
PISSN: 09349723
EISSN: None
Source Type: Journal
DOI: 10.1007/s10096-001-0644-6 Document Type: Article |
|
Times cited : (23)
|
|
References (28)
|
